Contact Information: Contact: Rachel Levine Director Corporate Development & Communications Cleveland BioLabs, Inc. T: (646) 284-9439 E: rlevine@cbiolabs.com
Buyins.net Initiates Coverage on Cleveland BioLabs With SqueezeTrigger Price of $7.41
| Source: Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwire - May 7, 2008) - Cleveland BioLabs, Inc. (NASDAQ : CBLI )
announced today that Buyins.net initiated coverage on the Company after
releasing the latest short sale data through May 2008.
The Buyins.net report stated that the total aggregate number of CBLI shares
shorted between July 2006 and May 2008 is approximately 2.5 million shares.
The report also stated that the CBLI SqueezeTrigger price of $7.41 is the
volume weighted average short price of all short selling in CBLI.
Interested parties should visit http://www.buyins.net for more information.
About Buyins.net
Buyins.net is a service designed to help shareholders of publicly traded US
companies fight naked short selling. Naked short selling is the illegal
act of short selling a stock when no affirmative determination has been
made to locate shares of the stock to hypothecate in connection with the
short sale.
About Cleveland BioLabs, Inc.
Cleveland BioLabs, Inc. is a drug discovery and development company
leveraging its proprietary discoveries about programmed cell death to treat
cancer and protect normal tissues from exposure to radiation and other
stresses. The Company has strategic partnerships with the Cleveland
Clinic, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed
Forces Radiobiology Research Institute. To learn more about Cleveland
BioLabs, Inc., please visit the company's website at
http://www.cbiolabs.com.
This press release does not suggest or imply an endorsement by the Company
of any recommendation or reference in any publication by unrelated parties.
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements reflect management's current expectations, as of the date of
this press release, and involve certain risks and uncertainties. The
Company's actual results could differ materially from those anticipated in
these forward-looking statements as a result of various factors. Some of
the factors that could cause future results to materially differ from the
recent results or those projected in forward-looking statements include the
"Risk Factors" described in the Company's periodic filings with the
Securities and Exchange Commission.